Clinical Trial Update: A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A placebo-controlled Phase 2 trial evaluated recombinant factor XIII (rFXIII) in adults with mild to moderate active ulcerative colitis; the study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• rFXIII (recombinant factor XIII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2014-08-05